Abstract:A structure-guided small-molecule and chemoproteomics approach uncovers a catalytic site inhibitor selective for the jumonji subfamily of H3K27me3 demethylases; the inhibitor decreases lipopolysaccharide-induced proinflammatory cytokine production by human primary macrophages. Jumonji (JMJ) family histone demethylases have become recognized as key regulators of transcription, although the importance of their enzymatic activity - as opposed to their structural role - has been unclear. JMJD3 demethylases are specific for histone H3 trimethylated at Lys27 (H3K27me3) and are involved in the inflammatory response, as well as other physiological functions. Here, a structure-guided small-molecule and chemoproteomics approach is used to discover a catalytic-site inhibitor selective for the H3K27me3-specific JMJ subfamily. The inhibitor reduces lipopolysaccharide-induced pro-inflammatory cytokine production in human primary macrophages. This study demonstrates the importance of JMJ demethylase activity and suggests that small-molecule inhibitors of JMJ enzymes could have therapeutic applications. The jumonji (JMJ) family of histone demethylases are Fe2+- and α-ketoglutarate-dependent oxygenases that are essential components of regulatory transcriptional chromatin complexes1,2,3,4. These enzymes demethylate lysine residues in histones in a methylation-state and sequence-specific context5. Considerable effort has been devoted to gaining a mechanistic understanding of the roles of histone lysine demethylases in eukaryotic transcription, genome integrity and epigenetic inheritance2,4,6, as well as in development, physiology and disease3,7. However, because of the absence of any selective inhibitors, the relevance of the demethylase activity of JMJ enzymes in regulating cellular responses remains poorly understood. Here we present a structure-guided small-molecule and chemoproteomics approach to elucidating the functional role of the H3K27me3-specific demethylase subfamily (KDM6 subfamily members JMJD3 and UTX)8. The liganded structures of human and mouse JMJD3 provide novel insight into the specificity determinants for cofactor, substrate and inhibitor recognition by the KDM6 subfamily of demethylases. We exploited these structural features to generate the first small-molecule catalytic site inhibitor that is selective for the H3K27me3-specific JMJ subfamily. We demonstrate that this inhibitor binds in a novel manner and reduces lipopolysaccharide-induced proinflammatory cytokine production by human primary macrophages, a process that depends on both JMJD3 and UTX. Our results resolve the ambiguity associated with the catalytic function of H3K27-specific JMJs in regulating disease-relevant inflammatory responses and provide encouragement for designing small-molecule inhibitors to allow selective pharmacological intervention across the JMJ family.

Jumonji Domain-Containing Protein 3 Regulates the Early Inflammatory Response Epigenetically in Human Periodontal Ligament Cells.

Epigenetic Modulation In Periodontitis: Interaction Of Adiponectin And Jmjd3-Irf4 Axis In Macrophages

Emerging role of Jumonji domain-containing protein D3 (JMJD3) in inflammatory diseases

The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing

Histone Methylation Mechanisms Modulate the Inflammatory Response of Periodontal Ligament Progenitors

METTL3 and METTL14 regulate IL-6 expression via RNA m6A modification of zinc transporter SLC39A9 and DNA methylation of IL-6 in periodontal ligament cells

Jmjd3 Regulates Inflammasome Activation and Aggravates DSS‐induced Colitis in Mice

Histone Demethylase JMJD3 Regulates Fibroblast‐like Synoviocyte‐mediated Proliferation and Joint Destruction in Rheumatoid Arthritis

JMJD3 Promotes Porphyromonas gingivalis Lipopolysaccharide-Induced Th17-Cell Differentiation by Modulating the STAT3-RORc Signaling Pathway

Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process

The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.

Critical Role of Histone Demethylase Jmjd3 in the Regulation of Cd4(+) T-Cell Differentiation

JMJD3 in the Regulation of Human Diseases

Changes in N6-methyladenosine RNA Methylomes of Human Periodontal Ligament Cells in Response to Inflammatory Conditions

Critical Role of Histone Demethylase Jumonji Domain-Containing Protein 3 in the Regulation of Neointima Formation Following Vascular Injury

JMJD3 as an epigenetic regulator in development and disease

Jmjd3-mediated Epigenetic Regulation of Inflammatory Cytokine Gene Expression in Serum Amyloid A-stimulated Macrophages.

A Selective Jumonji H3K27 Demethylase Inhibitor Modulates the Proinflammatory Macrophage Response

The JMJD3 histone demethylase inhibitor GSK-J1 ameliorates lipopolysaccharide-induced inflammation in a mastitis model

The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation.

JAK3 Restrains Inflammatory Responses and Protects Against Periodontal Disease Through Wnt3a Signaling.